Balyasny Asset Management LLC Gilead Sciences, Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 25,500 shares of GILD stock, worth $2.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,500

Previous 3,500 628.57%

Holding current value

$2.4 Million

Previous $240,000 790.42%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $13.6 Million - $17.2 Million	204,320 Added 137.32%	353,113 $29.6 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $2.13 Million - $2.45 Million	33,684 Added 29.26%	148,793 $10.2 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $6.33 Million - $7.72 Million	88,468 Added 332.07%	115,109 $8.43 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $1.11 Million - $1.26 Million	15,213 Added 133.12%	26,641 $2.16 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $844,986 - $921,896	11,428 New	11,428 $856,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $4.12 Million - $4.69 Million	-53,303 Reduced 12.61%	369,463 $30.7 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $18.2 Million - $26.2 Million	-292,753 Reduced 40.91%	422,766 $36.3 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $165,461 - $188,999	2,779 Added 0.39%	715,519 $44.1 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $7.29 Million - $8.21 Million	-126,258 Reduced 15.05%	712,740 $44.1 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $27.7 Million - $34.7 Million	478,510 Added 132.74%	838,998 $49.9 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $7.79 Million - $8.89 Million	129,886 Added 56.32%	360,488 $23.3 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $1.05 Million - $1.19 Million	-18,449 Reduced 7.41%	230,602 $13.4 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $15.5 Million - $19.4 Million	249,051 New	249,051 $15.7 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $2.17 Million - $2.4 Million	-34,762 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $15.7 Million - $17.6 Million	-253,782 Reduced 87.95%	34,762 $2.35 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.03 Million - $1.15 Million	16,467 Added 6.05%	288,544 $18.8 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $16.5 Million - $21.5 Million	272,077 New	272,077 $17 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $24.9 Million - $27.6 Million	-349,373 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $12.5 Million - $14.6 Million	-193,407 Reduced 35.63%	349,373 $24.8 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $27.6 Million - $33.6 Million	378,243 Added 229.88%	542,780 $40.9 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $708,369 - $831,525	-9,956 Reduced 5.71%	164,537 $11.8 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $12.6 Million - $14.9 Million	174,493	174,493 $14.1 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Gilead Sciences, Inc. Transaction History